Back

Perioperative empagliflozin and risk of acute kidney injury after cardiac surgery: a systematic review and meta-analysis

31 August 2026 (08:15 - 08:45)
Organised by: Logo
Congress Presentation Part of: Cardiotoxicity of drugs: machine learning and aortic stenosis Diuretics ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Gabriel Almeida Alves

(Brazil)

4 More presentations in this session

Presentation thumbnail
Targeting cardiac remodeling and sirtuin gene expression in type 1 diabetes mellitus: role of dapagliflozin
Mrs G. Brandao (Botucatu, BR)
Abstract Slides Video
Presentation thumbnail
Semaglutide attenuates diabetic vascular calcification by enhancing autophagy and lysosomal function via targeting CPNE1
Doctor S. Xiao (Nanjing, CN)
Abstract Slides Video
Presentation thumbnail
GLP-1 receptor agonist reduces anthracycline– and trastuzumab–induced cardiac dysfunction and systemic hs-CRP, IL-1β and IL-6 in non-diabetic preclinical models
Doctor N. Maurea (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Effects of dapagliflozin administration under sustained arterial hypertension
Miss A. Santos (Botucatu, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiotoxicity of drugs: machine learning and aortic stenosis

The Event

Event poster

ESC Congress 2026

31 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Effects of SGLT2i in the perioperative care of cardiac surgery: a systematic review and meta-analysis of randomised controlled trials
30 August 2026
thumbnail
Congress Presentation
Kidney parameters of the EMPAGHF cohort.
28 August 2022
thumbnail
Congress Presentation
Early postoperative administration of proton pump inhibitors and acute kidney injury after cardiac surgery
31 August 2026
thumbnail
Congress Presentation
Chronic kidney disease as a potent amplifier of acute kidney injury and mortality following mitral transcatheter edge-to-edge repair (M-TEER): a systematic review and meta-analysis
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources